# Nabilone for Agitation Blinded Intervention Trial

> **NCT04516057** · PHASE3 · RECRUITING · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 112 (estimated)

## Conditions studied

- Alzheimer Disease
- Agitation

## Interventions

- **DRUG:** Nabilone
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04516057
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-02-01
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2026-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04516057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04516057, "Nabilone for Agitation Blinded Intervention Trial". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT04516057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*